Voyager Therapeutics, Inc. (VYGR) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$3.87
Day's range
$4.12

Voyager Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 5.57 M $21.49 M   -0.89% 9.49%
ARMISTICE CAPITAL, LLC 05/15/2026 3.50 M $13.51 M   -12.50% 5.96%
MILLENNIUM MANAGEMENT LLC 05/15/2026 3.43 M $13.23 M   82.30% 5.84%
VESTAL POINT CAPITAL, LP 05/15/2026 3.00 M $11.59 M   103.59% 5.12%
05/15/2026 2.28 M $8.81 M   100.00% 3.89%
OPALEYE MANAGEMENT INC. 05/15/2026 1.15 M $4.44 M   -3.92% 1.96%
ERSTE ASSET MANAGEMENT GMBH 05/11/2026 1.10 M $4.24 M   -8.37% 1.87%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 1.05 M $4.05 M   -7.51% 1.79%
STATE STREET CORP 05/15/2026 948.23 K $3.66 M   1.28% 1.62%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 875.57 K $3.38 M   -19.27% 1.49%
05/08/2026 725.77 K $2.80 M   100.00% 1.24%
MORGAN STANLEY 05/15/2026 681.71 K $2.63 M   25.29% 1.16%
TWO SIGMA INVESTMENTS, LP 05/15/2026 615.66 K $2.38 M   176.44% 1.05%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 578.02 K $2.23 M   94.98% 0.98%
SPHERA FUNDS MANAGEMENT LTD. 05/15/2026 469.76 K $1.81 M   38.26% 0.80%
GOLDMAN SACHS GROUP INC 05/15/2026 427.60 K $1.65 M   41.06% 0.73%
DIADEMA PARTNERS LP 05/15/2026 423.64 K $1.64 M   100.00% 0.72%
NORTHERN TRUST CORP 05/14/2026 384.84 K $1.49 M   4.42% 0.66%
CITADEL ADVISORS LLC 05/15/2026 364.66 K $1.41 M   -34.49% 0.62%
FIDUCIARY TRUST CO 05/15/2026 334.40 K $1.29 M   0.00% 0.57%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 298.32 K $1.15 M   100.00% 0.51%
JPMORGAN CHASE & CO 05/13/2026 276.87 K $1.07 M   -15.13% 0.47%
ALTSHULER SHAHAM LTD 05/18/2026 273.93 K $1.06 M   34.45% 0.47%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 268.22 K $1.04 M   181.30% 0.46%
ACADIAN ASSET MANAGEMENT LLC 05/13/2026 248.87 K $957.00 K   147.67% 0.42%
AQR CAPITAL MANAGEMENT LLC 05/15/2026 232.68 K $898.15 K   45.39% 0.40%
PATRIOT FINANCIAL GROUP INSURANCE AGENCY, LLC 04/22/2026 205.73 K $794.13 K   100.29% 0.35%
WOODLINE PARTNERS LP 05/15/2026 193.98 K $748.78 K   100.00% 0.33%
FMR LLC 05/15/2026 163.68 K $631.81 K   15.48% 0.28%
HUDSON BAY CAPITAL MANAGEMENT LP 05/13/2026 156.25 K $603.13 K   100.00% 0.27%
DIADEMA PARTNERS LP 05/15/2026 150.00 K $579.00 K   100.00% 0.26%
AMERICAN CENTURY COMPANIES INC 05/15/2026 147.65 K $569.92 K   -1.83% 0.25%
BANK OF NEW YORK MELLON CORP 05/05/2026 139.77 K $539.51 K   0.31% 0.24%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 125.11 K $482.94 K   -9.26% 0.21%
PRIVIUM FUND MANAGEMENT B.V. 05/05/2026 120.00 K $463.20 K   26.32% 0.20%
INVESCO LTD. 05/12/2026 119.17 K $460.00 K   2.73% 0.20%
NUVEEN, LLC 04/30/2026 117.10 K $452.01 K   25.70% 0.20%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 117.08 K $452.00 K   -77.56% 0.20%
06/04/2026 115.20 K $444.68 K   100.00% 0.20%
BANK OF AMERICA CORP /DE/ 05/18/2026 107.43 K $414.68 K   -38.99% 0.18%
PERSISTENT ASSET PARTNERS LTD 05/12/2026 107.09 K $413.38 K   100.00% 0.18%
CAPTRUST FINANCIAL ADVISORS 05/15/2026 104.85 K $404.74 K   1.16% 0.18%
WELLS FARGO & COMPANY/MN 05/11/2026 101.72 K $392.65 K   -23.32% 0.17%
BARCLAYS PLC 05/15/2026 100.09 K $386.35 K   -38.26% 0.17%
D. E. SHAW & CO., INC. 05/15/2026 98.72 K $381.04 K   100.00% 0.17%
JANE STREET GROUP, LLC 05/12/2026 97.96 K $378.14 K   -34.58% 0.17%
UBS GROUP AG 05/05/2026 94.68 K $365.46 K   -64.78% 0.16%
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC 05/15/2026 89.71 K $346.30 K   100.00% 0.15%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2026 87.46 K $337.59 K   0.00% 0.15%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 78.89 K $304.52 K   21.03% 0.13%

Voyager Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 181 institutional investors and hedge funds held shares of Voyager Therapeutics Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 5.57 M

ARMISTICE CAPITAL, LLC: 3.5 M

MILLENNIUM MANAGEMENT LLC: 3.43 M

Vestal Point Capital, LP: 3 M

Opaleye Management Inc.: 1.15 M

Erste Asset Management GmbH: 1.1 M

57.11% of Voyager Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 43.14 M shares in the last 24 months. This purchase volume represents approximately $177.30 M in transactions.